The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer

Breast Cancer Research and Treatment

Volumn 116, Issue 1, 2009, Pages 53-68

  Jones, Robin L ^a   Salter, Janine ^a   A'Hern, Roger ^b   Nerurkar, Ash ^a   Parton, Marina ^a   Reis Filho, Jorge S ^b   Smith, Ian E ^a   Dowsett, Mitchell ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Breast cancer; Neoadjuvant chemotherapy; Post therapy proliferation

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; KI 67 ANTIGEN; METHOTREXATE; MITOXANTRONE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; MENSTRUATION; NEEDLE BIOPSY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; KI-67 ANTIGEN; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 67649442993     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0081-7     Document Type: Article

References (23)

1. RL Jones IE Smith 2006 Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour response Lancet Oncol 7 869 874 10.1016/S1470-2045(06)70906-8
2. A Urruticoechea IE Smith M Dowsett 2005 Proliferation marker Ki-67 in early breast cancer J Clin Oncol 23 7212 7220 10.1200/JCO.2005.07.501
3. E de Azambuja F Cardoso G de Castro Jr 2007 Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12, 155 patients Br J Cancer 96 1504 1513 10.1038/sj.bjc.6603756
4. J Gerdes H Lemke H Baisch HH Wacker U Schwab H Stein 1984 Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67 J Immunol 133 1710 1715 (Pubitemid 14035254)
5. P Querzoli G Albonico S Ferretti 1996 MIB-1 proliferative activity in invasive breast cancer measured by image analysis J Clin Pathol 49 926 930 10.1136/jcp.49.11.926 (Pubitemid 26403164)
6. CD Archer M Parton IE Smith 2003 Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer Br J Cancer 89 1035 1041 10.1038/sj.bjc.6601173
7. PA Ellis IE Smith S Detre 1998 Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy Breast Cancer Res Treat 48 107 116 10.1023/A:1005933815809
8. M Dowsett IE Smith SR Ebbs 2007 Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer J Natl Cancer Inst 99 167 170 10.1093/jnci/djk020
9. CW Elston IO Ellis 1991 Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 403 410 10.1111/j.1365-2559. 1991.tb00229.x
10. J Lee YH Im SH Lee 2008 Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer Cancer Chemother Pharmacol 61 569 577 10.1007/s00280-007-0506-8
11. M Takada A Kataoka M Toi 2004 A close association between alteration in growth kinetics by neoadjuvant chemotherapy and survival outcome in primary breast cancer Int J Oncol 25 397 405
12. AM Billgren LE Rutqvist E Tani N Wilking T Fornander L Skoog 1999 Proliferating fraction during neoadjuvant chemotherapy of primary breast cancer in relation to objective local response and relapse-free survival Acta Oncol 38 597 601 10.1080/028418699431186
13. KL Osborne CR X-J Xie R Ashfaq A Bian D Tripathy 2006 Neoadjuvant chemotherapy for basal-like breast cancer cohort: clinical and pathological outcomes Breast Cancer Res Treat 100 1 S53
14. M Colleoni G Viale D Zahrieh 2004 Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment Clin Cancer Res 10 6622 6628 10.1158/1078-0432.CCR-04- 0380
15. A Bottini A Berruti A Bersiga 2001 Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer Br J Cancer 85 1106 1112 10.1054/bjoc.2001.2048
16. F Penault-Llorca A Cayre F Bouchet Mishellany 2003 Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome Int J Oncol 22 1319 1325
17. IF Faneyte JG Schrama JL Peterse PL Remijnse S Rodenhuis MJ van de Vijver 2003 Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome Br J Cancer 88 406 412 10.1038/sj.bjc.6600749
18. A Schneeweiss J Katretchko HP Sinn 2004 Only grading has independent impact on breast cancer survival after adjustment for pathological response to preoperative chemotherapy Anticancer Drugs 15 127 135 10.1097/00001813- 200402000-00005 (Pubitemid 38316745)
19. Daidone MG, Veneroni S, Benini E et al (1999) Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancer. Int J Cancer 84:580-586. doi:10.1002/(SICI)1097-0215(19991222)84:6≤580::AID- IJC7≥3.0.CO;2-W
20. A Bottini A Berruti A Bersiga 1996 Effect of neoadjuvant chemotherapy on Ki67 labelling index, c-erbB-2 expression and steroid hormone receptor status in human breast tumours Anticancer Res 16 3105 3110 (Pubitemid 26390257)
21. AH Honkoop PJ van Diest JS de Jong 1998 Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer Br J Cancer 77 621 626 (Pubitemid 28059470)
22. A Vincent-Salomon A Rousseau M Jouve 2004 Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy Eur J Cancer 40 1502 1508 10.1016/j.ejca.2004.03.014
23. X Li MT Lewis J Huang 2008 Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy J Natl Cancer Inst 100 672 679 10.1093/jnci/djn123